BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9530346)

  • 1. Genomic amplification of CCND2 is rare in non-Hodgkin lymphomas.
    Andreasson P; Johansson B; Arheden K; Kristoffersson U; Akerman M; Mitelman F; Höglund M
    Cancer Genet Cytogenet; 1998 Apr; 102(1):81-2. PubMed ID: 9530346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of 12p abnormalities in hematologic malignancies: deletion of KIP1, rearrangement of TEL, and amplification of CCND2.
    Höglund M; Johansson B; Pedersen-Bjergaard J; Marynen P; Mitelman F
    Blood; 1996 Jan; 87(1):324-30. PubMed ID: 8547659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulation of cyclin D2 by juxtaposition with T-cell receptor alpha/delta locus in t(12;14)(p13;q11)-positive childhood T-cell acute lymphoblastic leukemia.
    Karrman K; Andersson A; Björgvinsdóttir H; Strömbeck B; Lassen C; Olofsson T; Nguyen-Khac F; Berger R; Bernard O; Fioretos T; Johansson B
    Eur J Haematol; 2006 Jul; 77(1):27-34. PubMed ID: 16548914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias.
    Clappier E; Cuccuini W; Cayuela JM; Vecchione D; Baruchel A; Dombret H; Sigaux F; Soulier J
    Leukemia; 2006 Jan; 20(1):82-6. PubMed ID: 16270038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas.
    Büschges R; Weber RG; Actor B; Lichter P; Collins VP; Reifenberger G
    Brain Pathol; 1999 Jul; 9(3):435-42; discussion 432-3. PubMed ID: 10416984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome analysis of non-Hodgkin's lymphomas by fluorescence in situ hybridization.
    Hammond DW; Hancock BW; Goyns MH
    Ann Oncol; 1994; 5 Suppl 1():51-4. PubMed ID: 8172818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D2 promoter disrupted by t(12;22)(p13;q11.2) during transformation of chronic lymphocytic leukaemia to non-Hodgkin's lymphoma.
    Qian L; Gong J; Liu J; Broome JD; Koduru PR
    Br J Haematol; 1999 Aug; 106(2):477-85. PubMed ID: 10460609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization.
    Wessendorf S; Schwaenen C; Kohlhammer H; Kienle D; Wrobel G; Barth TF; Nessling M; Möller P; Döhner H; Lichter P; Bentz M
    Oncogene; 2003 Mar; 22(9):1425-9. PubMed ID: 12618769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactivity for cyclin D3 is frequently detectable in high-grade primary gastric lymphomas in the absence of the t(6;14)(p21.1;q32.3) chromosomal translocation.
    Pruneri G; Fabris S; Fasani R; Del Curto B; Capella C; Pozzi B; Motta T; Andreola S; Ferreri AJ; Ponzoni M; Viale G; Neri A
    J Pathol; 2003 Aug; 200(5):596-601. PubMed ID: 12898595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
    Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
    Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.
    Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M
    Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDX1 is required for testicular tumorigenesis, partially through the transcriptional activation of 12p stem cell genes.
    Tanaka K; Okamoto S; Ishikawa Y; Tamura H; Hara T
    Oncogene; 2009 May; 28(21):2142-51. PubMed ID: 19398953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus.
    Shiller SM; Zieske A; Holmes H; Feldman AL; Law ME; Saad R
    Cancer Genet; 2011 Mar; 204(3):162-4. PubMed ID: 21504716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic analysis of non Hodgkin's lymphomas by ratio-painting and comparative genomic hybridization reveals unsuspected chromosomal abnormalities.
    Alqahtani MH; Hammond DW; Goepel JR; Goyns MH
    Leuk Lymphoma; 1999 Oct; 35(3-4):325-37. PubMed ID: 10706457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of genetic material from the short arm of chromosome 12 is a frequent secondary abnormality in non-Hodgkin's lymphoma.
    Jonveaux P; Le Coniat M; Derré J; Vecchione D; Berger R
    Hematol Pathol; 1991; 5(1):21-6. PubMed ID: 2050601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclin D2 and D3 in lymphoid lesions.
    Teramoto N; Pokrovskaja K; Szekely L; Polack A; Yoshino T; Akagi T; Klein G
    Int J Cancer; 1999 May; 81(4):543-50. PubMed ID: 10225442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression.
    Mai S; Hanley-Hyde J; Rainey GJ; Kuschak TI; Paul JT; Littlewood TD; Mischak H; Stevens LM; Henderson DW; Mushinski JF
    Neoplasia; 1999 Aug; 1(3):241-52. PubMed ID: 10935479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2.
    Joos S; Granzow M; Holtgreve-Grez H; Siebert R; Harder L; Martín-Subero JI; Wolf J; Adamowicz M; Barth TF; Lichter P; Jauch A
    Int J Cancer; 2003 Feb; 103(4):489-95. PubMed ID: 12478664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the activation state of the X chromosome in non-Hodgkin's lymphomas.
    Grierson AJ; Hammond DW; Goepel JR; Hancock BW; Goyns MH
    Ann Oncol; 1994; 5 Suppl 1():47-50. PubMed ID: 8172817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overrepresentation of chromosome 12p sequences and karyotypic evolution in i(12p)-negative testicular germ-cell tumors revealed by fluorescence in situ hybridization.
    Suijkerbuijk RF; Sinke RJ; Meloni AM; Parrington JM; van Echten J; de Jong B; Oosterhuis JW; Sandberg AA; Geurts van Kessel A
    Cancer Genet Cytogenet; 1993 Oct; 70(2):85-93. PubMed ID: 8242603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.